Janney Montgomery Scott LLC
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 1329948
PHILADELPHIA, PA
Position in SPRY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$16,536,628
+$344,423 QoQ
Shares Held
2,064,498
+2.4% QoQ
Ownership
2.08%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#13
of 209 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. SPRY ranks #2 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
85,735 | $42,587,146 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
2,064,498 | $16,536,628 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,176 | $7,592,223 | |
| 4 | INCY |
Incyte Corp
|
52,727 | $5,977,132 | |
| 5 | EXEL |
Exelixis, Inc.
|
89,664 | $4,878,618 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
272,194 | $3,903,261 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
13,087 | $3,203,304 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
79,550 | $2,815,274 |
All Filings in SPRY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,536,628 | 2,064,498 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $16,192,205 | 2,016,464 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $15,003,242 | 1,287,832 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $12,190,851 | 1,213,020 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $10,320,366 | 591,425 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $5,644,256 | 448,669 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $286,516 | 27,158 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $422,791 | 29,158 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $208,375 | 24,486 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $250,246 | 24,486 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $129,355 | 23,605 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $90,992 | 24,072 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $267,792 | 39,969 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $327,081 | 50,243 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $458,180 | 53,714 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $433,134 | 82,033 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $375,061 | 88,458 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $296,826 | 84,566 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $564,308 | 84,731 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $154,969 | 15,528 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $497,576 | 16,108 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $691,971 | 15,860 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $507,747 | 10,957 | Shares | Sole | 2021-01-25 | |
| No filing history on record for this holder in this stock. | ||||||